Cementos Bio-Bio (XSGO:CEMENTOS) Cyclically Adjusted Revenue per Share: CLP1,439.82 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSGO:CEMENTOS Cementos Bio-Bio SA XSGO:CEMENTOS
31 GF Score
Price CLP1,730.00
GF Value CLP741.87
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Cementos Bio-Bio Cyclically Adjusted Revenue per Share?

Cementos Bio-Bio XSGO:CEMENTOS 31 Cyclically Adjusted Revenue per Share is CLP1,439.82 as of Dec. 2025. GuruFocus rates XSGO:CEMENTOS with a GF Score™ of 31/100 and a GF Value™ of CLP741.87 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cementos Bio-Bio's adjusted revenue per share for the three months ended in Dec. 2025 was CLP365.325. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CLP1,439.82 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Cementos Bio-Bio's average Cyclically Adjusted Revenue Growth Rate was 0.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cementos Bio-Bio was 3.70% per year. The lowest was 0.80% per year. And the median was 3.65% per year.

As of today (2026-07-20), Cementos Bio-Bio's current stock price is CLP1730.00. Cementos Bio-Bio's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was CLP1,439.82. Cementos Bio-Bio's Cyclically Adjusted PS Ratio of today is 1.20.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cementos Bio-Bio was 1.26. The lowest was 0.45. And the median was 0.55.


Cementos Bio-Bio  (XSGO:CEMENTOS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cementos Bio-Bio's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1730.00/1439.82
=1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cementos Bio-Bio was 1.26. The lowest was 0.45. And the median was 0.55.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cementos Bio-Bio Cyclically Adjusted Revenue per Share Related Terms


Cementos Bio-Bio Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cementos Bio-Bio's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cementos Bio-Bio Cyclically Adjusted Revenue per Share Chart

Cementos Bio-Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,291.05 1,403.87 1,403.21 1,434.85 1,439.82

Cementos Bio-Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,434.85 1,455.88 1,448.17 1,449.68 1,439.82

XSGO:CEMENTOS vs CRH, VMC, MLM: Cyclically Adjusted Revenue per Share Comparison

For the Building Materials subindustry, Cementos Bio-Bio's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cementos Bio-Bio Cyclically Adjusted PS Ratio vs Building Materials Industry

For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cementos Bio-Bio's Cyclically Adjusted PS Ratio falls into.


XSGO:CEMENTOS
31GF Score
Cementos Bio-Bio SA XSGO:CEMENTOS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cementos Bio-Bio Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cementos Bio-Bio's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=365.325/158.0400*158.0400
=365.325

Current CPI (Dec. 2025) = 158.0400.

Cementos Bio-Bio Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 290.806 102.930 446.507
201606 284.091 103.965 431.854
201609 263.512 104.521 398.442
201612 208.626 104.532 315.419
201703 239.731 105.752 358.264
201706 242.865 105.730 363.022
201709 240.106 106.035 357.866
201712 264.258 106.907 390.651
201803 251.657 107.670 369.388
201806 231.989 108.421 338.158
201809 234.580 109.369 338.971
201812 270.392 109.653 389.711
201903 266.160 110.339 381.225
201906 241.168 111.352 342.285
201909 234.110 111.821 330.876
201912 271.627 112.943 380.085
202003 257.637 114.468 355.705
202006 195.869 114.283 270.864
202009 192.088 115.275 263.350
202012 281.216 116.299 382.148
202103 253.799 117.770 340.583
202106 254.198 118.630 338.644
202109 290.825 121.431 378.504
202112 295.542 124.634 374.757
202203 291.211 128.850 357.182
202206 295.312 133.448 349.732
202209 322.423 138.101 368.975
202212 354.718 140.574 398.791
202303 333.013 143.145 367.664
202306 312.502 143.538 344.076
202309 313.536 145.172 341.328
202312 361.594 146.109 391.121
202403 370.811 148.551 394.498
202406 318.988 149.592 337.002
202409 318.229 151.212 332.598
202412 352.820 152.774 364.981
202503 352.453 155.783 357.560
202506 348.001 155.754 353.109
202509 336.609 157.870 336.971
202512 365.325 158.040 365.325

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CLP1,439.82 mean?
Cementos Bio-Bio (XSGO:CEMENTOS) has a Cyclically Adjusted Revenue per Share of CLP1,439.82 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cementos Bio-Bio and its competitors.
Is Cementos Bio-Bio's Cyclically Adjusted Revenue per Share too high?
Cementos Bio-Bio's current Cyclically Adjusted Revenue per Share is CLP1,439.82. Overall, Cementos Bio-Bio has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's Cyclically Adjusted Revenue per Share compare to CRH and VMC?
Cementos Bio-Bio's Cyclically Adjusted Revenue per Share of CLP1,439.82 can be compared against companies in the Building Materials industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Building Materials company?
A good Cyclically Adjusted Revenue per Share depends on the Building Materials industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cementos Bio-Bio and its competitors. Cementos Bio-Bio's current Cyclically Adjusted Revenue per Share is CLP1,439.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Based on GuruFocus' analysis, Cementos Bio-Bio (XSGO:CEMENTOS) is currently considered Significantly Overvalued. The stock's GF Value™ is CLP741.87, compared to a current price of CLP1,730.00 — trading 133.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is CLP1,439.82. Cementos Bio-Bio's overall GF Score™ is 31/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current Cyclically Adjusted Revenue per Share is CLP1,439.82 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?

Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued. The current stock price of CLP1,730.00 is trading 133.2% above its estimated GF Value™ of CLP741.87. GuruFocus considers Cementos Bio-Bio to be Significantly Overvalued.

Key valuation signals for XSGO:CEMENTOS:

  • Cyclically Adjusted Revenue per Share: CLP1,439.82
  • GF Value™: CLP741.87 vs. price of CLP1,730.00 (133.2% above fair value)
  • GF Score™: 31/100 with 8 warning signs

No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cementos Bio-Bio Business Description

Address Barros Errazuriz No.1968, Piso 6, Santiago, CHL
Cementos Bio-Bio SA is a cement manufacturing company. The company manufactures and distributes construction materials.
31GF Score

Get the complete analysis for XSGO:CEMENTOS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CLP1,730.00
Price
CLP741.87
GF Value